Computational approaches for drug repurposing in oncology: untapped opportunity for high value innovation

Area of Science:

• Oncology
• Pharmacology
• Computational Biology

Background:

• Developing new cancer drugs faces significant challenges in academia and industry.
• Approved drugs offer a promising avenue for rapid therapeutic development in oncology.
• Drug repurposing addresses unmet needs in cancer treatment and complication management.

Purpose of the Study:

• To review computational approaches for drug repurposing in oncology.
• To highlight strategies for identifying existing drugs for new cancer therapies.

Main Methods:

• Review of computational methodologies.
• Analysis of drug repurposing strategies.
• Focus on applications in oncology.

Main Results:

• Computational methods can effectively identify potential drug repurposing candidates.
• Existing approved drugs can be leveraged for novel oncologic indications.
• This strategy accelerates the development of much-needed cancer therapeutics.

Conclusions:

• Computational drug repurposing is a viable strategy for advancing cancer treatment.
• Harnessing existing drugs can overcome traditional drug development hurdles.
• This approach holds significant promise for improving patient outcomes in oncology.